These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 4624843)

  • 21. Tophaceous gout in patients with renal transplants treated with cyclosporine A.
    Baethge BA; Work J; Landreneau MD; McDonald JC
    J Rheumatol; 1993 Apr; 20(4):718-20. PubMed ID: 8496871
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gout.
    Roddy E; Mallen CD; Doherty M
    BMJ; 2013 Oct; 347():f5648. PubMed ID: 24473446
    [No Abstract]   [Full Text] [Related]  

  • 23. [Observations on a random group of gout patients].
    Einaudi G; Marrazzi G; Pecchiura G
    Reumatismo; 1972; 24(1):21-9. PubMed ID: 4671625
    [No Abstract]   [Full Text] [Related]  

  • 24. Urate-oxidase for the treatment of tophaceous gout in heart transplant recipients. A report of three cases.
    Rozenberg S; Roche B; Dorent R; Koeger AC; Borget C; Wrona N; Bourgeois P
    Rev Rhum Engl Ed; 1995 May; 62(5):392-4. PubMed ID: 7655872
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Reducing the risks in the treatment of gout and hyperuricaemia (author's transl)].
    Mertz DP
    Dtsch Med Wochenschr; 1976 Aug; 101(35):1288-92. PubMed ID: 782809
    [No Abstract]   [Full Text] [Related]  

  • 26. [Treatment with allopurinol in gout and hyperuricemic renal disease].
    Hood B; Olander R
    Lakartidningen; 1973 Mar; 70(13):1297-300. PubMed ID: 4699017
    [No Abstract]   [Full Text] [Related]  

  • 27. An allopurinol-controlled, randomized, double-dummy, double-blind, parallel between-group, comparative study of febuxostat (TMX-67), a non-purine-selective inhibitor of xanthine oxidase, in patients with hyperuricemia including those with gout in Japan: phase 3 clinical study.
    Kamatani N; Fujimori S; Hada T; Hosoya T; Kohri K; Nakamura T; Ueda T; Yamamoto T; Yamanaka H; Matsuzawa Y
    J Clin Rheumatol; 2011 Jun; 17(4 Suppl 2):S13-8. PubMed ID: 21654265
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Allopurinol in the treatment of gout].
    Klein G; Griendl W; Kalb R
    Z Rheumaforsch; 1968 Dec; 27(11):455-60. PubMed ID: 5710881
    [No Abstract]   [Full Text] [Related]  

  • 29. [Allopurinol and gouty hyperuricemia : apropos of 30 cases treated by a single daily dose].
    Appelboom T; Famaey JP
    Brux Med; 1977 Mar; 57(3):133-7. PubMed ID: 861817
    [No Abstract]   [Full Text] [Related]  

  • 30. Diagnosis and management of gout.
    Pittman JR; Bross MH
    Am Fam Physician; 1999 Apr; 59(7):1799-806, 1810. PubMed ID: 10208700
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intermittent control of hyperuricemia in the treatment of gout.
    Bull PW; Scott JT
    J Rheumatol; 1989 Sep; 16(9):1246-8. PubMed ID: 2681764
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Effectiveness and tolerance of long-term uricosuric treatment].
    Berg H
    Z Gesamte Inn Med; 1990 Dec; 45(23):719-20. PubMed ID: 2102029
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gout.
    Haslock I; Wright V; Chamney B
    Nurs Mirror Midwives J; 1975 Jan; 140(4):49-53. PubMed ID: 803682
    [No Abstract]   [Full Text] [Related]  

  • 34. Hyperuricemia and gout: an update.
    Khachadurian AK
    Am Fam Physician; 1981 Dec; 24(6):143-8. PubMed ID: 6895439
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chronic gouty nephropathy treated by long-term hemodialysis and allopurinol.
    Johnson WJ; O'Duffy JD
    Mayo Clin Proc; 1979 Sep; 54(9):618-20. PubMed ID: 470461
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Therapy of hyperuricemia and gout. Effect of a combination therapy of allopurinol with benzbromarone].
    Matzkies F
    Fortschr Med; 1983 May; 101(20):953-9. PubMed ID: 6873850
    [No Abstract]   [Full Text] [Related]  

  • 37. Does starting allopurinol prolong acute treated gout? A randomized clinical trial.
    Hill EM; Sky K; Sit M; Collamer A; Higgs J
    J Clin Rheumatol; 2015 Apr; 21(3):120-5. PubMed ID: 25807090
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Uric-acid reduction with high allopurinol dosages (author's transl)].
    Mertz DP; Loewer H
    Dtsch Med Wochenschr; 1979 Mar; 104(9):324-5. PubMed ID: 761542
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metabolic diseases: gout.
    Falasca GF
    Clin Dermatol; 2006; 24(6):498-508. PubMed ID: 17113968
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of noncompliance with urate-lowering drug on serum urate and gout-related healthcare costs: administrative claims analysis.
    Halpern R; Mody RR; Fuldeore MJ; Patel PA; Mikuls TR
    Curr Med Res Opin; 2009 Jul; 25(7):1711-9. PubMed ID: 19485724
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.